Scalp Cooling Treatment Reduces Hair Loss

Scalp Cooling Treatment Reduces Hair Loss Research shows that for most cancer patients, hair loss is the most feared side effect of chemotherapy. Many chemotherapy drugs cause hair loss because they target rapidly dividing cells in the body, with hair cells among the fastest-dividing.

Breast cancer patients at Greenwich Hospital now have access to the Paxman Scalp Cooling System that can potentially reduce hair loss associated with chemotherapy.

With this new system, patients wear a cooling cap on their heads before, during and after chemo treatment. Scalp cooling reduces the damage to hair follicles by cooling the scalp, which reduces blood flow to the area around the follicles. While results vary, studies show patients who use scalp cooling tend to lose less hair, and use head coverings or wigs less often.

Used in Canada and Europe for years, the Paxman system was approved in 2017 by the Food and Drug Administration for use in the United States as a prescriptive device to reduce hair loss for breast cancer patients. Outcome data from clinical trials helps Greenwich Hospital oncology nurses provide this service as part of the best possible care for breast cancer patients.